SERPINA1 Methylation Levels are Associated with Lung Cancer Development in Male Patients with Chronic Obstructive Pulmonary Disease

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Molins L, Agusti A. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol. 2013;8(4):e34. doi:10.1097/JTO.0b013e318286c1c1
   PubMed Web of Science ®Google Scholar
• Seijo LM, Zulueta JJ. Understanding the links between lung cancer, COPD, and emphysema: a key to more effective treatment and screening. Oncology. 2017;31(2):93–102.
   PubMed Web of Science ®Google Scholar
• Ocak S, Sos ML, Thomas RK, Massion PP. High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications. Eur Respir J. 2009;34(2):489–506. doi:10.1183/09031936.00042409
   PubMed Web of Science ®Google Scholar
• Thun GA, Imboden M, Ferrarotti I, et al. Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. PLoS Genet. 2013;9(8):e1003585. doi:10.1371/journal.pgen.1003585
   PubMed Web of Science ®Google Scholar
• Beckmeyer-Borowko A, Imboden M, Rezwan FI, et al. SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts. Respir Res. 2018;19(1):156. doi:10.1186/s12931-018-0850-8
   PubMed Web of Science ®Google Scholar
• Qiu W, Baccarelli A, Carey VJ, et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med. 2012;185(4):373–381. doi:10.1164/rccm.201108-1382OC
   PubMed Web of Science ®Google Scholar
• Pérez-Rubio G, Ambrocio-Ortiz E, López-Flores LA, et al. Heterozygous Genotype rs17580 AT (PiS) in SERPINA1 is associated with COPD secondary to biomass-burning and tobacco smoking: a case-control and populational study. Int J Chron Obstruct Pulmon Dis. 2020;15:1181–1190. doi:10.2147/COPD.S247446
   PubMed Web of Science ®Google Scholar
• Ercetin E, Richtmann S, Delgado BM, et al. Clinical Significance of SERPINA1 gene and its encoded alpha1-antitrypsin protein in NSCLC. Cancers. 2019;11(9):1306. doi:10.3390/cancers11091306
   PubMed Web of Science ®Google Scholar
• Senn O, Russi EW, Imboden M, Probst-Hensch NM. alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. Eur Respir J. 2005;26(5):909–917. doi:10.1183/09031936.05.00021605
   PubMed Web of Science ®Google Scholar
• Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008;3:16. doi:10.1186/1750-1172-3-16
   PubMed Web of Science ®Google Scholar
• Borel F, Sun H, Zieger M, et al. Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema. Proc Natl Acad Sci U S A. 2018;115(11):2788–2793. doi:10.1073/pnas.1713689115
   PubMed Web of Science ®Google Scholar
• Deng X, Yuan CH, Chang D. Interactions between single nucleotide polymorphism of SERPINA1 gene and smoking in association with COPD: a case-control study. Int J Chron Obstruct Pulmon Dis. 2017;12:259–265. doi:10.2147/COPD.S116313
   PubMed Web of Science ®Google Scholar
• Scamuffa N, Siegfried G, Bontemps Y, et al. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest. 2008;118(1):352–363. doi:10.1172/JCI32040
   PubMed Web of Science ®Google Scholar
• Normandin K, Péant B, Le Page C, et al. Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. Clin Exp Metastasis. 2010;27(1):55–69. doi:10.1007/s10585-009-9303-6
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock IM, Casolari P, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax. 2011;66(6):521–527. doi:10.1136/thx.2010.156448
   PubMed Web of Science ®Google Scholar
• Constâncio V, Nunes SP, Henrique R, Jerónimo C. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells. 2020;9(3):624. doi:10.3390/cells9030624
   PubMed Web of Science ®Google Scholar
• Schiffman JD, Fisher PG, Gibbs P. Early detection of cancer: past, present, and future. Am Soc Clin Oncol Educ Book. 2015;57–65. doi:10.14694/EdBook_AM.2015.35.57
   PubMedGoogle Scholar
• Klutstein M, Nejman D, Greenfield R, Cedar H. DNA methylation in cancer and aging. Cancer Res. 2016;76(12):3446–3450. doi:10.1158/0008-5472.CAN-15-3278
   PubMed Web of Science ®Google Scholar
• O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(2):180–184. doi:10.1513/pats.200508-093DO
   PubMedGoogle Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
   PubMed Web of Science ®Google Scholar
• Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37–49. doi:10.1093/carcin/bgp272
   PubMed Web of Science ®Google Scholar
• Kim RY, Pinkerton JW, Essilfie AT, et al. Role for NLRP3 Inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant Asthma. Am J Respir Crit Care Med. 2017;196(3):283–297. doi:10.1164/rccm.201609-1830OC
   PubMed Web of Science ®Google Scholar
• Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10105):1833–1842. doi:10.1016/S0140-6736(17)32247-X
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chandra V, Riquelme Sanchez E, et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med. 2020;217(12):e20190354. doi:10.1084/jem.20190354
   PubMed Web of Science ®Google Scholar
• Saito A, Horie M, Nagase T. TGF-β signaling in lung health and disease. Int J Mol Sci. 2018;19(8):2460. doi:10.3390/ijms19082460
   PubMed Web of Science ®Google Scholar